Imprivata (NYSE:IMPR) Earning Positive Press Coverage, Study Finds

News headlines about Imprivata (NYSE:IMPR) have trended positive this week, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Imprivata earned a daily sentiment score of 0.28 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 46.5218729406262 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of NYSE:IMPR traded up $0.01 during mid-day trading on Thursday, reaching $19.26. The company had a trading volume of 199,900 shares, compared to its average volume of 258,396. Imprivata has a 52-week low of $9.00 and a 52-week high of $20.32. The company has a market capitalization of $492.60 and a price-to-earnings ratio of -20.27.

How to Become a New Pot Stock Millionaire

TRADEMARK VIOLATION NOTICE: “Imprivata (NYSE:IMPR) Earning Positive Press Coverage, Study Finds” was first reported by BBNS and is the sole property of of BBNS. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://baseballnewssource.com/2018/03/30/imprivata-impr-getting-favorable-news-coverage-analysis-shows/1973378.html.

Imprivata Company Profile

Imprivata, Inc (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure.

Insider Buying and Selling by Quarter for Imprivata (NYSE:IMPR)

Receive News & Ratings for Imprivata Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Almora Jr. and Baez Could Become Cubs new One-Two Tandem
Red Sox Tie Record for Best Start After 17 Games
Red Sox Tie Record for Best Start After 17 Games
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL


Leave a Reply

 
© 2006-2018 BBNS.